Mount Sinai — New York, New York

Public research footprint of Mount Sinai, compiled from the ClinicalTrials.gov public registry.

4,282

Registered studies

1,204

Active

666

Recruiting now

2,406

Completed

529

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Ann Arbor Stage IV Lymphocyte-Depleted Classic Hodgkin Lymphoma · X-Linked Protoporphyria (XLP)

Recently updated registry entries

NCT07521475 — Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes (Recruiting)
NCT06952504 — A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab… (Recruiting)
NCT07015983 — A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Mount Sinai?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.